JUBILANT PHARMOVA
Back to Income Statement
|
JUBILANT PHARMOVA Last 5 Year Revenue History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Sales | ₹6,282 Cr | ₹6,130 Cr | ₹6,099 Cr | ₹5,976 Cr | ₹9,111 Cr |
What is the latest Revenue of JUBILANT PHARMOVA ?
Year | Revenue |
---|---|
Mar2024 | ₹6,282 Cr |
Mar2023 | ₹6,130 Cr |
Mar2022 | ₹6,099 Cr |
Mar2021 | ₹5,976 Cr |
Mar2020 | ₹9,111 Cr |
How is Revenue of JUBILANT PHARMOVA Trending?
Years | Revenue | % Change | |
---|---|---|---|
Mar2024 | ₹6,282 Cr | 2.47 | |
Mar2023 | ₹6,130 Cr | 0.52 | |
Mar2022 | ₹6,099 Cr | 2.05 | |
Mar2021 | ₹5,976 Cr | -34.41 | |
Mar2020 | ₹9,111 Cr | - |
Compare Revenue of peers of JUBILANT PHARMOVA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
JUBILANT PHARMOVA | ₹18,758.4 Cr | -3.7% | -0.1% | 62.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹407,551.0 Cr | 0.4% | 1.8% | 4.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹175,704.0 Cr | -1.1% | 0.1% | 45.6% | Stock Analytics | |
CIPLA | ₹123,675.0 Cr | 3.8% | 1.2% | -1.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹121,925.0 Cr | 2.2% | 11.7% | 11.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹106,626.0 Cr | 1.4% | -3.3% | -7.2% | Stock Analytics |
JUBILANT PHARMOVA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
JUBILANT PHARMOVA | -3.7% |
-0.1% |
62.6% |
SENSEX | -0.4% |
-1.6% |
1.3% |
You may also like the below Video Courses